Bisphosphonate Treatment for Children With Disabling Conditions

Alison M. Boyce, Laura L. Tosi, Scott M. Paul

Research output: Contribution to journalArticle

Abstract

Fractures are a frequent source of morbidity in children with disabling conditions. The assessment of bone density in this population is challenging, because densitometry is influenced by dynamic forces affecting the growing skeleton and may be further confounded by positioning difficulties and surgical hardware. First-line treatment for pediatric osteoporosis involves conservative measures, including optimizing the management of underlying conditions, maintaining appropriate calcium and vitamin D intake, encouraging weight-bearing physical activity, and monitoring measurements of bone mineral density. Bisphosphonates are a class of medications that increase bone mineral density by inhibiting bone resorption. Although bisphosphonates are commonly prescribed for treatment of adult osteoporosis, their use in pediatric patients is controversial because of the lack of long-term safety and efficacy data.

Original languageEnglish (US)
Pages (from-to)427-436
Number of pages10
JournalPM and R
Volume6
Issue number5
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Diphosphonates
Bone Density
Osteoporosis
Pediatrics
Densitometry
Weight-Bearing
Bone Resorption
Skeleton
Vitamin D
Therapeutics
Exercise
Calcium
Morbidity
Safety
Population

ASJC Scopus subject areas

  • Rehabilitation
  • Neurology
  • Clinical Neurology
  • Physical Therapy, Sports Therapy and Rehabilitation
  • Medicine(all)

Cite this

Bisphosphonate Treatment for Children With Disabling Conditions. / Boyce, Alison M.; Tosi, Laura L.; Paul, Scott M.

In: PM and R, Vol. 6, No. 5, 2014, p. 427-436.

Research output: Contribution to journalArticle

Boyce, Alison M. ; Tosi, Laura L. ; Paul, Scott M. / Bisphosphonate Treatment for Children With Disabling Conditions. In: PM and R. 2014 ; Vol. 6, No. 5. pp. 427-436.
@article{1bc8663902524cdca394aab522f33c63,
title = "Bisphosphonate Treatment for Children With Disabling Conditions",
abstract = "Fractures are a frequent source of morbidity in children with disabling conditions. The assessment of bone density in this population is challenging, because densitometry is influenced by dynamic forces affecting the growing skeleton and may be further confounded by positioning difficulties and surgical hardware. First-line treatment for pediatric osteoporosis involves conservative measures, including optimizing the management of underlying conditions, maintaining appropriate calcium and vitamin D intake, encouraging weight-bearing physical activity, and monitoring measurements of bone mineral density. Bisphosphonates are a class of medications that increase bone mineral density by inhibiting bone resorption. Although bisphosphonates are commonly prescribed for treatment of adult osteoporosis, their use in pediatric patients is controversial because of the lack of long-term safety and efficacy data.",
author = "Boyce, {Alison M.} and Tosi, {Laura L.} and Paul, {Scott M.}",
year = "2014",
doi = "10.1016/j.pmrj.2013.10.009",
language = "English (US)",
volume = "6",
pages = "427--436",
journal = "PM and R",
issn = "1934-1482",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Bisphosphonate Treatment for Children With Disabling Conditions

AU - Boyce, Alison M.

AU - Tosi, Laura L.

AU - Paul, Scott M.

PY - 2014

Y1 - 2014

N2 - Fractures are a frequent source of morbidity in children with disabling conditions. The assessment of bone density in this population is challenging, because densitometry is influenced by dynamic forces affecting the growing skeleton and may be further confounded by positioning difficulties and surgical hardware. First-line treatment for pediatric osteoporosis involves conservative measures, including optimizing the management of underlying conditions, maintaining appropriate calcium and vitamin D intake, encouraging weight-bearing physical activity, and monitoring measurements of bone mineral density. Bisphosphonates are a class of medications that increase bone mineral density by inhibiting bone resorption. Although bisphosphonates are commonly prescribed for treatment of adult osteoporosis, their use in pediatric patients is controversial because of the lack of long-term safety and efficacy data.

AB - Fractures are a frequent source of morbidity in children with disabling conditions. The assessment of bone density in this population is challenging, because densitometry is influenced by dynamic forces affecting the growing skeleton and may be further confounded by positioning difficulties and surgical hardware. First-line treatment for pediatric osteoporosis involves conservative measures, including optimizing the management of underlying conditions, maintaining appropriate calcium and vitamin D intake, encouraging weight-bearing physical activity, and monitoring measurements of bone mineral density. Bisphosphonates are a class of medications that increase bone mineral density by inhibiting bone resorption. Although bisphosphonates are commonly prescribed for treatment of adult osteoporosis, their use in pediatric patients is controversial because of the lack of long-term safety and efficacy data.

UR - http://www.scopus.com/inward/record.url?scp=84901498516&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901498516&partnerID=8YFLogxK

U2 - 10.1016/j.pmrj.2013.10.009

DO - 10.1016/j.pmrj.2013.10.009

M3 - Article

VL - 6

SP - 427

EP - 436

JO - PM and R

JF - PM and R

SN - 1934-1482

IS - 5

ER -